Biogen Inc.

Biogen Inc.verified

BIIB

Price:

$217.81

Market Cap:

$31.71B

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of AN...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1991-09-17

Stock Exchange

NASDAQ

Ticker

BIIB

The PE Ratio as of May 2024 (TTM) for Biogen Inc. (BIIB) is 27.23

According to Biogen Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 27.23. This represents a change of -276.14% compared to the average of -15.46 of the last 4 quarters.

Biogen Inc. (BIIB) Historical PE Ratio (quarterly & annually)

How has BIIB PE Ratio performed in the past?

The mean historical PE Ratio of Biogen Inc. over the last ten years is 19.23. The current 27.23 PE Ratio has changed 14.06% with respect to the historical average. Over the past ten years (40 quarters), BIIB's PE Ratio was at its highest in in the December 2023 quarter at 37.54. The PE Ratio was at its lowest in in the September 2023 quarter at -136.62.

Quarterly (TTM)
Annual

Average

19.23

Median

18.33

Minimum

9.43

Maximum

32.25

Biogen Inc. (BIIB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Biogen Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 144.20%

Maximum Annual PE Ratio = 32.25

Minimum Annual Increase = -47.83%

Minimum Annual PE Ratio = 9.43

Quarterly (TTM)
Annual
YearPE RatioChange
202332.25144.20%
202213.21-42.55%
202122.99133.43%
20209.854.45%
20199.43-32.25%
201813.92-47.83%
201726.6759.47%
201616.73-16.06%
201519.93-27.12%
201427.34-23.13%

Biogen Inc. (BIIB) Average PE Ratio

How has BIIB PE Ratio performed in the past?

The current PE Ratio of Biogen Inc. (BIIB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

22.81

5-year avg

17.54

10-year avg

19.23

Biogen Inc. (BIIB) PE Ratio vs. Peers

How is BIIB’s PE Ratio compared to its peers?

Biogen Inc.’s PE Ratio is greater than Bristol-Myers Squibb Company (-13.57), less than AbbVie Inc. (46.36), less than Merck & Co., Inc. (142.24), less than Gilead Sciences, Inc. (169.22), greater than Johnson & Johnson (9.20), less than Amgen Inc. (43.56), greater than Pfizer Inc. (-551.94), greater than Sanofi (15.83), greater than Novartis AG (13.48), less than GSK plc (32.14),

CompanyPE RatioMarket cap
-13.57$83.60B
46.36$277.35B
142.24$327.97B
169.22$81.83B
9.20$353.71B
43.56$164.06B
-551.94$163.65B
15.83$121.63B
13.48$196.69B
32.14$92.00B

Build a custom stock screener for Biogen Inc. (BIIB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biogen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biogen Inc. (BIIB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biogen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Biogen Inc.'s PE Ratio?

How is the PE Ratio calculated for Biogen Inc. (BIIB)?

What is the highest PE Ratio for Biogen Inc. (BIIB)?

What is the 3-year average PE Ratio for Biogen Inc. (BIIB)?

What is the 5-year average PE Ratio for Biogen Inc. (BIIB)?

How does the current PE Ratio for Biogen Inc. (BIIB) compare to its historical average?